Brief: Innate Pharma Announces Advancement Of Sanofi-Sponsored Clinical Trial For Blood Cancer Patients

Innate Pharma SA

15/04/2024 06:23

April 15 (Reuters) - Innate Pharma SA  IPH.PA :
    * INNATE PHARMA ANNOUNCES ADVANCEMENT OF SANOFI-DEVELOPED NK
CELL
ENGAGER SAR443579 / IPH6101 PROGRESSING TO PHASE 2 FOR BLOOD
CANCER PATIENTS
    * DOSING OF FIRST PATIENT IN DOSE EXPANSION PART OF TRIAL
TRIGGERS
A EUR 4M MILESTONE PAYMENT TO INNATE

Source text for WorkSpace: ID:nBw5hLcPza 
Further company coverage: IPH.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))